Add like
Add dislike
Add to saved papers

Evaluation of Ocular Surface and Meibomian Glands Alterations with Meibography in Patients with Inactive Behçet's Uveitis.

Current Eye Research 2018 November 31
PURPOSE: To evaluate the ocular surface and meibography of patients with inactive Behçet's uveitis.

METHODS: Twenty-five right eyes of 25 patients with inactive Behçet's uveitis (Group 1) and 25 right eyes of 25 healthy individuals (Group 2) were enrolled. Detailed eye examination along with Schirmer 1 test, tear film break-up time (t-BUT), ocular surface staining with fluorescein and Oxford scoring, ocular surface disease index (OSDI) score assessment were performed. Lower and upper eyelid Meibomian glands were examined with infrared filter of slit-lamp biomicroscope (SL-D701 with DC-4 digital camera and BG-5 background illuminator, TOPCON, Tokyo, Japan (from grade 0 (no dropout of Meibomian glands) to grade 3 (gland dropout >2/3 of the total Meibomian glands)).

RESULTS: The mean ages were 36.84 ± 7.39 (range, 23-59) and 33.88 ± 8.25 (range, 18-55) in Group 1 and Group 2, respectively (p = 0.547). When compared with Group 2 in Group 1, best-corrected visual acuity (0.28 vs 0.00 logMAR, p < 0.001), Schirmer 1 test (18.68 vs. 23.69, p = 0.017), mean tear film break-up time (10.76 vs. 13.36, p = 0.026) were significantly lower; Oxford scale and OSDI scores were higher (p = 0.039 and p < 0.001, respectively). No significant difference in lower, upper and total (upper + lower) meiboscores were detected in between groups (p = 0.062, p = 0.228 and p = 0.152, respectively).

CONCLUSION: Despite the tendency toward dry eye syndrome, Behçet's uveitis does not seem to be associated with quantitative Meibomian gland changes which is demonstrated by gland drop-out with meibography.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app